TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2017-05-12
What TuHURA BIOSCIENCES, INC./NV reported in its quarterly report filed 2017-05-12 (fiscal Q3 2017): 23 published measures, 62 facts as tagged in accession 0001213900-17-005082.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-05-12
- Fiscal period
- fiscal Q3 2017
- Accession
- 0001213900-17-005082 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TuHURA BIOSCIENCES, INC./NV filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 2,340,891 | USD | |
| At 2016-06-30 | 6,355,799 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 1,110,754 | USD | |
| At 2016-06-30 | 1,497,021 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 1,230,137 | USD | |
| At 2016-06-30 | 4,858,778 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 2,100,406 | USD | |
| At 2016-06-30 | 6,157,264 | USD | |
| At 2016-03-31 | 937,355 | USD | |
| At 2015-06-30 | 1,754,433 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-03-31 | 1,868,460 | USD | 90 |
| 2016-07-01 to 2017-03-31 | -5,480,772 | USD | 274 |
| 2015-07-01 to 2016-03-31 | -5,408,479 | USD | 275 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2017-03-31 | -4,569,908 | USD | 274 |
| 2015-07-01 to 2016-03-31 | -3,592,218 | USD | 275 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2017-03-31 | 513,050 | USD | 274 |
| 2015-07-01 to 2016-03-31 | 2,791,902 | USD | 275 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2016-03-31 | -16,762 | USD | 275 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | -38,401,763 | USD | |
| At 2016-06-30 | -32,237,859 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-03-31 | 11,574,052 | shares | 90 |
| 2016-07-01 to 2017-03-31 | 11,432,376 | shares | 274 |
| 2016-01-01 to 2016-03-31 | 11,077,275 | shares | 91 |
| 2015-07-01 to 2016-03-31 | 10,896,887 | shares | 275 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2017-03-31 | 106,571 | USD | 274 |
| 2015-07-01 to 2016-03-31 | 138,711 | USD | 275 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 2,316,448 | USD | |
| At 2016-06-30 | 6,319,782 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 1,019,209 | USD | |
| At 2016-06-30 | 627,446 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 24,443 | USD | |
| At 2016-06-30 | 36,017 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-03-31 | -1,784,232 | USD | 90 |
| 2016-07-01 to 2017-03-31 | -5,525,796 | USD | 274 |
| 2016-01-01 to 2016-03-31 | -1,420,549 | USD | 91 |
| 2015-07-01 to 2016-03-31 | -4,178,278 | USD | 275 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-03-31 | -1,086,107 | USD | 90 |
| 2016-07-01 to 2017-03-31 | -2,939,746 | USD | 274 |
| 2016-01-01 to 2016-03-31 | -790,323 | USD | 91 |
| 2015-07-01 to 2016-03-31 | -2,183,355 | USD | 275 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 11,187,023 | shares | |
| At 2016-06-30 | 11,187,023 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 21,178 | USD | |
| At 2016-06-30 | 21,178 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 91,545 | USD | |
| At 2016-03-31 | 1,017,250 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-03-31 | 1,868,460 | USD | 90 |
| 2016-07-01 to 2017-03-31 | 5,480,772 | USD | 274 |
| 2016-01-01 to 2016-03-31 | 1,140,401 | USD | 91 |
| 2015-07-01 to 2016-03-31 | 5,408,479 | USD | 275 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-03-31 | 2,078,271 | USD | 90 |
| 2016-07-01 to 2017-03-31 | 6,157,637 | USD | 274 |
| 2016-01-01 to 2016-03-31 | 1,140,401 | USD | 91 |
| 2015-07-01 to 2016-03-31 | 5,408,479 | USD | 275 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-03-31 | -698,125 | USD | 90 |
| 2016-07-01 to 2017-03-31 | -2,586,050 | USD | 274 |
| 2016-01-01 to 2016-03-31 | -630,226 | USD | 91 |
| 2015-07-01 to 2016-03-31 | -1,994,923 | USD | 275 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-03-31 | 84,228 | USD | 90 |
| 2016-07-01 to 2017-03-31 | -45,024 | USD | 274 |
| 2016-01-01 to 2016-03-31 | -280,148 | USD | 91 |
| 2015-07-01 to 2016-03-31 | 1,230,201 | USD | 275 |
Inspect the source
- Entity
- TuHURA BIOSCIENCES, INC./NV / CIK 0001498382
- Captured
- 2026-09-20T09:11:11.339Z
- SEC response SHA-256
cbfb2cda3307f7af300be1fc56e9d85ca5186f16e46a189d675574c95ee74f5c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001498382.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))